NEPHROTIC SYNDROME: HISTOPATHOLOGICAL DIFFERENTIAL DIAGNOSTICS. PART 3: MEMBRANOUS PROLIFERATIVE GLOMERULONEPHRITIS, IGA NEPHROPATHY, DIABE TIC NEPHROPATHY, AMYLOIDOSIS, POST-TRANSPLANT NEPHROPATHY

nephrotic syndrome, definition, classification, morphology, pathophysiology, diagnostics

1. Andresdottir MB, Assmann KJ, Koene RA, Wetzels JF. Immunohistological and ultrastructural differences between recurrent type I membranoproliferative glomerulonephritis and chronic transplant glomerulopathy. Am J Kidney Dis 1998; 32: 582-588

2. Bariety J, Nochy D, Mandet C et al. Podocytes undergo phenotypic changes and express macrophagic-associated markers in idiopathic collapsing glomerulopathy. Kidney Int 1998; 53: 918-925

3. Benigni A, Gagliardini E, Tomasoni S et al. Selective impairment of gene expression and assembly of nephrin in human diabetic nephropathy.Kidney Int 2004; 65: 2193-2200

4. Cameron JS. Focal segmental glomerulosclerosis in adults. Nephrol Dial Transplant2003;18[suppl 6]: vi 45-51

5. D’Agati VD, Fogo AB, Bruijn JA, Jennette JC. Pathologic classification of focal segmental glomerulosclerosis: a working proposal. Am J Kidney Dis 2004; 43: 368-382

6. Grone EF, Walli AK, Grone HJ et al. The role of lipids in nephrosclerosis and glomerulosclerosis. Atherosclerosis 1994; 107: 1-13

7. Grone HJ, Grone EF, Malle E. Immunohistochemical detection of hypochlorite-modified proteins in glomeruli of human membranous glomerulonephritis. Lab Invest 2002; 82(1): 5-14

8. Hawkins PN. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002; 6; 346: 1786-1791

9. Heidet L, Bongers EM, Sich M et al. In vivo expression of putative LMX1B targets in nail-patella syndrome kidneys. Am J Pathol 2003; 163: 145-155

10. Janssen B, Hohenadel D, Brinkkoetter P et al. Carnosine as a protective factor in diabetic nephropathy: association with a leucine repeat of the carnosinase gene CNDP1. Diabetes 2005; 54 : 2320-2327

11. Kaplan JM, Kim SH, North KN et al. Mutations in ACTN4, encoding alpha-actinin-4, cause familial focal segmental glomerulosclerosis. Nat Genet 2000; 24: 251-256

12. Kriz W. Podocyte is the major culprit accounting for the progression of chronic renal disease. Microsc Res Tech 2002; 15; 57: 189-195

13. Kriz W. The pathogenesis of ‘classic’ focal segmental glomerulosclerosis-lessons from rat models. Nephrol Dial Transplant 2003; 18[Suppl 6]: vi 39-44

14. Lachmann HJ, Booth DR, Booth SE et al. Congenital nephrotic syndromes. Curr Opin Genet Dev 2001; 11: 322-327

15. Lahdenkari AT, Kestila M, Holmberg C et al. Nephrin gene (NPHS1) in patients with minimal change nephrotic syndrome (MCNS). Kidney Int 2004; 65: 1856-1863

16. Malle E, Buch T, Grone HJ. Myeloperoxidase in kidney disease. Kidney Int 2003; 64: 1956-1967

17. Markowitz GS, Schwimmer JA, Stokes MB et al. C1q nephropathy: a variant of focal segmental glomerulosclerosis. Kidney Int 2003; 64: 1232-1240

18. Marx BE, Marx M. Prediction in idiopathic membranous nephropathy. Kidney Int 1999; 56: 666-673

19. Matsuda M, Shikata K, Wada J et al. Deposition of mannan binding protein and mannan binding protein-mediated complement activation in the glomeruli of patients with IgA nephropathy. Nephron 1998; 80: 408-413

20. Merlini G, Westermark P. The systemic amyloidoses: clearer understanding of the molecular mechanisms offers hope for more effective therapies. J Intern Med 2004; 255: 159-178

21. Morello R, Lee B. Insight into podocyte differentiation from the study of human genetic disease: nail-patella syndrome and transcriptional regulation in podocytes. Pediatr Res 2002; 51: 551-558

22. Moudgil A, Nast CC, Bagga A et al. Association of parvovirus B19 infection with idiopathic collapsing glomerulopathy. Kidney Int 2001; 59: 2126-2133

23. Mundel P, Shankland SJ. Podocyte biology and response to injury. J Am Soc Nephrol 2002; 13: 3005-3015

24. Miner JH, Morello R, Andrews KL et al. Transcriptional induction of slit diaphragm genes by Lmx1b is required in podocyte differentiation. J Clin Invest 2002; 109: 1065-1072

25. Niaudet P. Genetic forms of nephrotic syndrome. Pediatr Nephrol 2004; 21

26. Sellin L, Huber TB, Gerke P et al. NEPH1 defines a novel family of podocin interacting proteins. FASEB J 2003; 17: 115-117

27. Somlo S, Mundel P. Getting a foothold in nephrotic syndrome. Nat Genet 2000; 24: 333-335

28. Stokes MB, Markowitz GS, Lin J et al. Glomerular tip lesion: a distinct entity within the minimal change disease / focal segmental glomerulosclerosis spectrum. Kidney Int 2004; 65: 1690-1702

29. van den Berg JG, van den Bergh Weerman MA, Assmann KJ et al. Podocyte foot process effacement is not correlated with the level of proteinuria in human glomerulopathies. Kidney Int 2004; 66: 1901-1906

30. van den Berg JG, Weening JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci (Lond) 2004; 107: 125-136

31. van Dijk C, Berl T. Pathogenesis of diabetic nephropathy. Rev Endocr Metab Disord 2004; 5: 237-248

32. Wolf G, Stahl RA. CD2-associated protein and glomerular disease. Lancet 2003; 362: 1746-1748

33. Yakupoglu U, Baranowska-Daca E, Rosen D et al. Post-transplant nephrotic syndrome: A comprehensive clinicopathologic study. Kidney Int 2004; 65: 2360-2370

34. Frasca GM, Soverini L, Gharavi AG et al. Thin basement membrane disease in patients with familial IgA nephropathy. J Nephrol 2004; 17: 778-7785

35. Suliman ME, Stenvinkel P, Barany P et al. Hyperhomocysteinemia, malnutrition, and inflammation in ESRD patients. Semin Nephrol 2006; 26(1): 14-19

36. Suissa S, Hutchinson T, Brophy JM, Kezouh A. ACE-inhibitor use and the long-term risk of renal failure in diabetes. Kidney Int 2006; 69: 913-919

37. Thomas DB, Franceschini N, Hogan SL et al. Clinical and pathologic characteristics of focal segmental glomerulosclerosis pathologic variants. Kidney Int 2006; 69: 920-926

38. Tisher CC, Brenner BM. Renal pathology with clinical and functional correlations. 1 ed. J.B. Lipincott Company, 1993

39. Heptinstall RH. Pathology of the kideny. 3rd ed. Little, Brown Co, 1983